BioWorld MedTech

Nov. 15, 2012

The MDD Interview: Chronic disease management cited as key market for VitalSims

Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes. Read More

Guided Therapeutics submits amended PMA for LuViva

Regional innovation review: Diverse range of medical device companies dot Atlanta's landscape

Washington roundup: Nexon: Failure 'not an option' for medical device tax repeal

Agreements/contracts: CPAC set to deliver DWA proton therapy system

Financings roundup: U.S. Bank closes two credit facilities for Trinity Health

Report from Europe: Stryker Ireland cancels plan to eliminate 142 jobs in 2013

Patent watch: T2 Biosystems expands IP with two new U.S. patents

New ventures: RVM forms new division of vascular access centers

Mindray initiates voluntary recall for anesthesia system

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...